Meeting
2021 ASCO Annual Meeting
Association of the presence of estrogen and progesterone receptors in uterine carcinosarcoma with improved survival and increased immunogenicity.
Authors
Nathaniel L. Jones
University of South Alabama, Mobile, AL
Nathaniel L. Jones , Sharon Wu , Joanne Xiu , Rodney Paul Rocconi , Britt Kristina Erickson , Premal H. Thaker , Jubilee Brown , Thomas J. Herzog , Robert W. Holloway , Wolfgang Michael Korn , Matthew A. Powell , Annelise M. Wilhite
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Uterine Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 5588)
DOI
10.1200/JCO.2021.39.15_suppl.5588
Abstract #
5588
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2014 Breast Cancer Symposium
Racial/ethnic disparities in estrogen and progesterone receptor phenotype and survival outcomes.
First Author: Raji Shameem
Poster
2023 ASCO Annual Meeting
Not all treated KRAS-mutant pancreatic adenocarcinomas are equal: KRAS G12D and survival outcome.
First Author: Bach Ardalan
Poster
2022 ASCO Annual Meeting
Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer.
First Author: Sung Jun Ma
Poster
2020 Genitourinary Cancers Symposium
Identification of genomic alterations in signaling pathways associated with poor survival in newly diagnosed metastatic prostate cancer (mCSPC) using artificial intelligence (AI).
First Author: Edwin Lin